Invesaro

Stocks CIEN Financial statements

Financial statements

CIENA CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CIENA CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2018FY2018FY2019FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Revenue3,0943,0943,5723,5723,5323,6213,6334,3874,0154,770
Cost of revenue1,7801,7802,0302,0301,8791,8992,0722,5082,2952,765
Gross profit1,3151,3151,5421,5421,6531,7221,5601,8791,7202,005
Research and development492492548548530537625751767848
Selling and marketing394394423423416452467491511581
General and administrative160160174174170182179215221239
Operating expenses1,0851,0851,1951,1951,1661,2271,3381,5211,5531,807
Operating income230230347347487495223358167198
Interest expense55.255.237.537.531.330.847.1889789.4
Other non-operating income-1.02-1.02-0.74-0.74-1.11-0.53-5.92-5.05-1.58-2.36
Pre-tax income149149313313456463183324120156
Income tax49349359.859.894.7-37.429.668.835.932.9
Net income-345-34525325336150015325584123
EBITDA314314434434581592319450259302
EPS, basic-2.40-2.401.631.632.343.221.011.710.580.87
EPS, diluted-2.49-2.491.611.612.323.191.001.710.580.85
Shares, basic (weighted)144144156156154155151149145142
Shares, diluted (weighted)144144158158156157152149146145

Balance sheet

FY2018FY2018FY2019FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents7457459049041,0891,4239941,0119351,092
Short-term investments149110110151181154105316216
Receivables7877257257198859211,004909976
Inventory2633453453443749471,051820826
Other current assets199298298308326370406564455
Total current assets2,1432,3822,3822,6113,1893,3863,5763,5443,566
Property, plant and equipment292287287272285268280338387
Lease right-of-use assets05744.345.135.127.438.6
Goodwill298298298311312328445445521
Intangible assets14811311396.665.369.5206165224
Long-term investments59101082.27035.413480.957.1
Other non-current assets71.7898910399.9114116155186
Total assets3,7573,8933,8934,1814,8655,0705,6015,6415,865
Accounts payable341345345292356516318423543
Accrued liabilities340383383334409361431394531
Deferred revenue111111111109118138154156209
Short-term debt76.936.936.9311.711.711.6
Total current liabilities9638468467619091,0419321,0001,308
Long-term debt6866806806766701,0611,5431,5331,524
Lease liabilities61.441.642.433.325.132.5
Other non-current liabilities119149149123167150170186175
Total liabilities1,8271,7211,7211,6711,8452,3572,7532,8253,135
Total debt6866806876836771,0681,5551,5451,536
Paid-in capital6,8816,8386,8386,8276,8036,3906,2626,1555,953
Retained earnings-4,948-4,644-4,644-4,283-3,785-3,632-3,377-3,293-3,170
Other comprehensive income-5.78-22.1-22.1-35.40.44-46.6-37.8-46.7-55
Shareholders' equity1,9291,9292,1732,1732,5103,0202,7132,8482,8162,729
Total equity1,9291,9292,1732,1732,5103,0202,7132,8482,8162,729
Total liabilities and equity3,7573,8933,8934,1814,8655,0705,6015,6415,865
Shares outstanding154154154155155148145143141

Cash flow statement

FY2018FY2018FY2019FY2020FY2020FY2021FY2022FY2023FY2024FY2025
Net income-345-34525325336150015325584123
Depreciation and amortization84.284.287.687.693.996.295.992.692.8104
Stock-based compensation535359.759.767.884.3105130156185
Deferred income tax46446419.919.964.3-156-27.5-14.9-76.8-23.2
Change in receivables-168-16865.765.7-17.3-174-47.1-94.680.3-98.7
Change in inventory-27.4-27.4-113-113-25-47.6-589-132153-53.6
Change in payables85.885.827.727.7-118162100-13864.3226
Cash from operations229229413413494542-168168515806
Capital expenditures-67.6-67.6-62.6-62.6-82.7-79.6-90.8-106-137-141
Acquisitions-82.7-82.700-28.30-62-2300-231
Purchases of investments-287-287-158-158-223-171-648-252-288-214
Sales and maturities of investments410410249249110150702208141349
Cash from investing-19.4-19.424.124.1-220-90.7-101-383-306-241
Debt issued305305000040000
Debt repaid-293-293-7-7-5.2-6.93-5.2-9.43-11.7-11.6
Stock issued23.123.122.922.928.128.530.331.434.335.9
Share buybacks-111-111-150-150-74.5-91.3-501-242-255-335
Cash from financing-99.2-99.2-279-279-87.2-117-133229-285-406
Exchange rate effect-5.86-5.860.480.48-1.64-0.2-26.22.151.25-1.51
Net change in cash105105159159185334-42816.4-75.8157
Free cash flow162162351351411462-25962.1378665
Interest paid44.844.839.639.632.829.942.884.592.585.2
Income taxes paid26.926.933.633.653.173.13578.255114

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to August 1, 2026; growth uses fiscal years. Valuation uses the share price of $356.91 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin44.1%Gross profit / revenue.
Operating margin12.3%Operating income / revenue.
EBITDA margin14.4%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin12.1%Pre-tax income / revenue.
Net margin10.9%Net income / revenue.
FCF margin13.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin17.5%Cash from operations / revenue.
Effective tax rate9.8%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)21.4%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)8.2%Net income / average total assets.
Return on invested capital (ROIC)17.4%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue15.4%Research and development expense / revenue.
Stock-based pay / revenue3.5%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue4.0%Capital expenditures / revenue.
D&A / revenue2.2%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y18.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y9.5%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y6.2%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y16.6%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y8.7%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y3.9%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y18.6%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y-3.9%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y-16.5%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y16.3%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y-1.8%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y-12.3%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y46.9%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y-6.9%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y-19.3%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y46.6%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y-5.3%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y-18.2%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y56.7%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 5y10.3%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y76.1%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y10.1%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y-3.1%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y0.2%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y1.7%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y4.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y5.0%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y7.0%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.5%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.5%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.4%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio3.80xCurrent assets / current liabilities.
Quick ratio2.79x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.90x(Cash + short-term investments) / current liabilities.
Debt / equity1.06xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets40.4%Total debt / total assets.
Liabilities / assets61.8%Total liabilities / total assets.
Net debt$599.8MTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.69xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage10.6xOperating income / interest expense.
Working capital$3.88BCurrent assets - current liabilities.
Goodwill and intangibles / assets8.8%(Goodwill + intangible assets) / total assets.
Tangible book value$2.35BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.75xRevenue / average total assets.
Fixed asset turnover12.2xRevenue / average property, plant and equipment.
Inventory turnover3.86xCost of revenue / average inventory.
Days inventory95 days365 x average inventory / cost of revenue.
Receivables turnover4.88xRevenue / average receivables.
Days sales outstanding75 days365 x average receivables / revenue.
Days payables71 days365 x average accounts payable / cost of revenue.
Cash conversion cycle98 daysDays inventory + days sales outstanding - days payables.
FCF conversion124.4%Free cash flow / net income, when net income is positive.
Capex / operating cash flow22.8%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$4.48Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$41.25Revenue / diluted weighted shares.
FCF per share$5.58Free cash flow / diluted weighted shares.
Operating cash flow per share$7.23Cash from operations / diluted weighted shares.
Book value per share$21.54Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share$16.59Tangible book value / shares outstanding.
Cash per share$18.53(Cash + short-term investments) / shares outstanding.
Buybacks / FCF51.9%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$50.52BShare price x shares outstanding.
Enterprise value$51.12BMarket cap + total debt - cash - short-term investments.
P/E77.2xMarket cap / net income. Only when net income is positive.
P/S8.39xMarket cap / revenue.
P/B16.5xMarket cap / shareholders' equity. Only when equity is positive.
Price / tangible book21.5xMarket cap / tangible book value, when positive.
P/FCF62.0xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF47.9xMarket cap / cash from operations, when positive.
EV/Sales8.49xEnterprise value / revenue.
EV/EBIT69.2xEnterprise value / operating income, when both are positive.
EV/EBITDA58.8xEnterprise value / EBITDA, when both are positive.
EV/FCF62.8xEnterprise value / free cash flow, when both are positive.
FCF yield1.6%Free cash flow / market cap.
Earnings yield1.3%Net income / market cap (the inverse of P/E).
Shareholder yield0.8%(Dividends paid + share buybacks) / market cap.
What was CIENA CORP's revenue in fiscal 2025?

CIENA CORP reported revenue of $4.77B for fiscal 2025, 18.8% higher than the year before.

Was CIENA CORP profitable in fiscal 2025?

Yes. Net income was $123.3M, a net margin of 2.6%.

How much free cash flow did CIENA CORP generate in fiscal 2025?

Cash from operations of $806.1M minus capital expenditures of $140.8M left free cash flow of $665.3M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CIENA CORP